These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1463 related items for PubMed ID: 19326408

  • 1. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE, Haworth SE, Belli LS, Burra P, Pinzello G, Vangeli M, Minola E, Guido M, Boccagni P, De Feo TM, Torelli R, Cardillo M, Scalamogna M, Poli F.
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [Abstract] [Full Text] [Related]

  • 2. Natural killer cells play divergent roles in shaping the outcome of hepatitis C virus recurrence following liver transplantation.
    Golden-Mason L.
    Liver Transpl; 2009 Apr; 15(4):357-9. PubMed ID: 19326413
    [No Abstract] [Full Text] [Related]

  • 3. KIR gene mismatching and KIR/C ligands in liver transplantation: consequences for short-term liver allograft injury.
    Legaz I, López-Álvarez MR, Campillo JA, Moya-Quiles MR, Bolarín JM, de la Peña J, Salgado G, Gimeno L, García-Alonso AM, Muro M, Miras M, Alonso C, Álvarez-López MR, Minguela A.
    Transplantation; 2013 Apr 27; 95(8):1037-44. PubMed ID: 23478359
    [Abstract] [Full Text] [Related]

  • 4. KIR genes and their human leukocyte antigen ligands in the progression to cirrhosis in patients with chronic hepatitis C.
    Marangon AV, Silva GF, de Moraes CF, Grotto RM, Pardini MI, de Pauli DS, Sell AM, Visentainer JE, Moliterno RA.
    Hum Immunol; 2011 Nov 27; 72(11):1074-8. PubMed ID: 21920398
    [Abstract] [Full Text] [Related]

  • 5. Absence of activating killer immunoglobulin-like receptor genes combined with hepatitis C viral genotype is predictive of hepatocellular carcinoma.
    Littera R, Zamboni F, Tondolo V, Fantola G, Chessa L, Orrù N, Sanna M, Valentini D, Cappai L, Mulargia M, Caocci G, Arras M, Floris A, Orrù S, La Nasa G, Carcassi C.
    Hum Immunol; 2013 Oct 27; 74(10):1288-94. PubMed ID: 23756163
    [Abstract] [Full Text] [Related]

  • 6. Natural killer cell HLA-C epitopes and killer cell immunoglobulin-like receptors both influence outcome of mismatched unrelated donor bone marrow transplants.
    De Santis D, Bishara A, Witt CS, Nagler A, Brautbar C, Slavin S, Christiansen FT.
    Tissue Antigens; 2005 Jun 27; 65(6):519-28. PubMed ID: 15896199
    [Abstract] [Full Text] [Related]

  • 7. Natural killer cells in hepatitis C virus recurrence following liver transplantation: what role do they play?
    de Arias AE, Haworth SE, Defeo TM, Poli F.
    Expert Rev Gastroenterol Hepatol; 2009 Aug 27; 3(4):329-32. PubMed ID: 19673619
    [No Abstract] [Full Text] [Related]

  • 8. KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy.
    Hsu KC, Gooley T, Malkki M, Pinto-Agnello C, Dupont B, Bignon JD, Bornhäuser M, Christiansen F, Gratwohl A, Morishima Y, Oudshoorn M, Ringden O, van Rood JJ, Petersdorf E, International Histocompatibility Working Group.
    Biol Blood Marrow Transplant; 2006 Aug 27; 12(8):828-36. PubMed ID: 16864053
    [Abstract] [Full Text] [Related]

  • 9. HLA and killer immunoglobulin-like receptor genes as outcome predictors of hepatitis C virus-related hepatocellular carcinoma.
    Cariani E, Pilli M, Zerbini A, Rota C, Olivani A, Zanelli P, Zanetti A, Trenti T, Ferrari C, Missale G.
    Clin Cancer Res; 2013 Oct 01; 19(19):5465-73. PubMed ID: 23938290
    [Abstract] [Full Text] [Related]

  • 10. Donor killer immunoglobulin-like receptor (KIR) genotype-patient cognate KIR ligand combination and antithymocyte globulin preadministration are critical factors in outcome of HLA-C-KIR ligand-mismatched T cell-replete unrelated bone marrow transplantation.
    Yabe T, Matsuo K, Hirayasu K, Kashiwase K, Kawamura-Ishii S, Tanaka H, Ogawa A, Takanashi M, Satake M, Nakajima K, Tokunaga K, Inoko H, Saji H, Ogawa S, Juji T, Sasazuki T, Kodera Y, Morishima Y, Japan Marrow Donor Program.
    Biol Blood Marrow Transplant; 2008 Jan 01; 14(1):75-87. PubMed ID: 18158964
    [Abstract] [Full Text] [Related]

  • 11. The role of missing killer cell immunoglobulin-like receptor ligands in T cell replete peripheral blood stem cell transplantation from HLA-identical siblings.
    Clausen J, Kircher B, Auberger J, Schumacher P, Ulmer H, Hetzenauer G, Wolf D, Gastl G, Nachbaur D.
    Biol Blood Marrow Transplant; 2010 Feb 01; 16(2):273-80. PubMed ID: 19857587
    [Abstract] [Full Text] [Related]

  • 12. Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation.
    Gagne K, Busson M, Bignon JD, Balère-Appert ML, Loiseau P, Dormoy A, Dubois V, Perrier P, Jollet I, Bois M, Masson D, Moine A, Absi L, Blaise D, Charron D, Raffoux C, ARS2000 FRM and FGM group.
    Biol Blood Marrow Transplant; 2009 Nov 01; 15(11):1366-75. PubMed ID: 19822295
    [Abstract] [Full Text] [Related]

  • 13. Influence of inhibitory killer immunoglobulin-like receptors and their HLA-C ligands on resolving hepatitis C virus infection.
    Rauch A, Laird R, McKinnon E, Telenti A, Furrer H, Weber R, Smillie D, Gaudieri S, Swiss HIV Cohort Study.
    Tissue Antigens; 2007 Apr 01; 69 Suppl 1():237-40. PubMed ID: 17445209
    [Abstract] [Full Text] [Related]

  • 14. Protective effect of the HLA-Bw4I80 epitope and the killer cell immunoglobulin-like receptor 3DS1 gene against the development of hepatocellular carcinoma in patients with hepatitis C virus infection.
    López-Vázquez A, Rodrigo L, Martínez-Borra J, Pérez R, Rodríguez M, Fdez-Morera JL, Fuentes D, Rodríguez-Rodero S, Gonzáez S, López-Larrea C.
    J Infect Dis; 2005 Jul 01; 192(1):162-5. PubMed ID: 15942906
    [Abstract] [Full Text] [Related]

  • 15. HLA-C matching and liver transplants: donor-recipient genotypes influence early outcome and CD8+KIR2D+ T-cells recuperation.
    López-Alvarez MR, Moya-Quiles MR, Minguela A, Gil J, Miras M, Campillo JA, Díaz-Alderete MA, García-Alonso AM, Sánchez-Bueno F, Vicario JL, Muro M, Alvarez-López MR.
    Transplantation; 2009 Aug 15; 88(3 Suppl):S54-61. PubMed ID: 19667963
    [Abstract] [Full Text] [Related]

  • 16. Killer cell immunoglobulin-like receptors and response to antiviral treatment in Thai patients with chronic hepatitis C virus genotype 3a.
    Vejbaesya S, Nonnoi Y, Tanwandee T, Srinak D.
    J Med Virol; 2011 Oct 15; 83(10):1733-7. PubMed ID: 21755501
    [Abstract] [Full Text] [Related]

  • 17. Hematopoietic stem cell transplantation: killer immunoglobulin-like receptor component.
    Hsu KC, Pinto-Agnello C, Gooley T, Malkki M, Dupont B, Petersdorf EW.
    Tissue Antigens; 2007 Apr 15; 69 Suppl 1():42-5. PubMed ID: 17445161
    [Abstract] [Full Text] [Related]

  • 18. Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.
    Gao X, Jiao Y, Wang L, Liu X, Sun W, Cui B, Chen Z, Zhao Y.
    Clin Immunol; 2010 Oct 15; 137(1):139-46. PubMed ID: 20643584
    [Abstract] [Full Text] [Related]

  • 19. Long-term outcome of hepatitis C infection after liver transplantation.
    Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, Maertens G, Williams R.
    N Engl J Med; 1996 Mar 28; 334(13):815-20. PubMed ID: 8596547
    [Abstract] [Full Text] [Related]

  • 20. Clinical outcomes of living donor liver transplantation for hepatitis C virus (HCV)-positive patients.
    Takada Y, Haga H, Ito T, Nabeshima M, Ogawa K, Kasahara M, Oike F, Ueda M, Egawa H, Tanaka K.
    Transplantation; 2006 Feb 15; 81(3):350-4. PubMed ID: 16477219
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 74.